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TRANSCRIPTIONAL SILENCING 
ELEMENTS AND THEIR BINDING FACTORS 
CROSS REFERENCE TO RELATED 
APPLICATION 
This application claims priority to provisional application 
60/020,087, ?led Jun. 13, 1996. +gi 
STATEMENT AS TO FEDERALLY SPONSORED 
RESEARCH 
This invention Was made in part With Government 
funding, and the Government therefore has certain rights in 
the invention. 
BACKGROUND OF THE INVENTION 
This application relates to nucleotide regulatory 
sequences and their binding factors. 
Plants have evolved a diverse array of mechanisms for 
protection against a variety of pathogenic organisms. 
Pathogen-derived signals such as elicitins, harpins, fungal 
cell Wall fragments, avirulence (avr) gene products, and 
metabolites speci?ed by avr gene products are recogniZed by 
receptors that trigger a conserved set of defense responses. 
Perception of these signals induces changes in protein 
phosphorylation that are thought to affect a variety of 
defense responses. Such defense responses include ligni? 
cation of cell Walls, induction of pathogenesis-related (PR) 
genes such as those encoding chitinases and glucanases, 
production of antimicrobial phytoalexins, induction of sys 
temic acquired resistance, and generation of reactive oxygen 
species involved in crosslinking of cell Wall proteins and 
induction of programmed cell death. These responses are 
instrumental in suppressing the groWth and spread of a 
pathogen Within the plant host. 
Many of these defense responses are dependent on the 
transcriptional induction of speci?c genes in response to 
appropriate signals. For example, When solanaceous plants 
such as tobacco and potato are challenged by a pathogen or 
elicited by various pathogen factors, a major metabolic shift 
occurs Where sterol production is suppressed and sesquiter 
pene phytoalexin synthesis is induced. The ?rst step speci?c 
to sesquiterpene phytoalexin biosynthesis is a cycliZation of 
the isoprenoid intermediate FPP by enZymes generically 
referred to as sesquiterpene cyclases. In tobacco, the ses 
quiterpene cyclase S-epi-aristolochene synthase (EAS) pro 
duces S-epi-aristolochene, folloWed by the addition of tWo 
hydroxyl groups to yield capsidiol. The sterol-speci?c 
branch of the isoprenoid biosynthetic pathWay also extends 
from the intermediate FPP. Declines in sterol biosynthesis 
have been correlated With suppression of squalene synthase 
enZyme activity, and the induction of sesquiterpene biosyn 
thesis With an induction of a sesquiterpene cyclase enZyme 
activity. Because these tWo enZymes are positioned at a 
putative branch point in the pathWay, the induction of one 
enZyme and the suppression of the other Were interpreted as 
an important mechanism controlling carbon How and, hence, 
end product formation. 
SUMMARY OF THE INVENTION 
In general, the invention features an isolated nucleic acid 
sequence that includes an isoprenoid synthase gene silencing 
regulatory element. Preferably, such a isolated nucleic acid 
sequence includes the sequence 5‘ NTACNNTACN 3‘ 
(Where N is A, T, G, or C) (SEQ ID NO: 1); for example, 5‘ 
CTACAGTACT 3‘ (SEQ ID NO: 2). In preferred 
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embodiments, the nucleic acid of the invention includes the 
5‘ TCTACAGTACT 3‘ (SEQ ID NO: 3) or 5‘ ACTCTA 
CAGTACTC 3‘ (SEQ ID NO: 4) sequences. In yet other 
preferred embodiments, the isoprenoid synthase is a sesquit 
erpene synthase (e.g., epi-S-aristolochene synthase (EAS)). 
In preferred embodiments, the nucleic acid sequence is 
from a dicot (e.g., a member of the Solanaceae such as 
Nicotiana). In other preferred embodiments, the nucleic acid 
sequence is from a monocot, a gymnosperm, or a conifer. 
In related aspects, the invention features a vector or a 
transgenic plant (or a seed or plant cell thereof) that includes 
an isoprenoid synthase gene silencing regulatory element. In 
general, the vector containing the silencing element of the 
invention reduces or eliminates the expression of an oper 
ably linked nucleotide sequence in a vector-containing cell 
(e.g., a transgenic plant cell). 
In another aspect, the invention features a method for 
decreasing the transcription of a DNA sequence in a trans 
genic plant. This method involves the steps of: (a) providing 
a transgenic plant cell Which includes the nucleic acid of an 
isoprenoid synthase gene silencing regulatory element posi 
tioned for decreasing transcription of a DNA sequence and 
integrated into the genome of said transgenic plant cell; and 
(b) groWing said transgenic plant from said transgenic plant 
cell. 
In another aspect, the invention features factors, e.g., a 
polypeptide, that bind to an isoprenoid synthase gene silenc 
ing regulatory element. 
By “gene silencing regulatory element” is meant a nucleic 
acid sequence capable of negatively regulating the expres 
sion of a gene product. Such silencing elements function to 
reduce or eliminate the expression of a gene. Repression of 
a gene silencing regulatory element results in the activation 
of gene expression, e.g., transcription of the EAS4 gene 
promoter described herein. In general, gene silencing regu 
latory elements are located in the 5‘ region of a gene, e.g., in 
the promoter region. Multiple copies of such gene silencing 
elements may also be used to reduce or eliminate gene 
expression. 
By “positioned for decreasing transcription of a DNA 
sequence” is meant that a silencing regulatory element is 
positioned to decrease or eliminate expression of a gene that 
is under the control of such a regulatory element. Such 
silencing elements, in general, are suf?cient to render 
promoter-dependent gene expression controllable for cell- or 
tissue-speci?c gene expression, or gene expression that is 
inducible by external signals or agents; such elements may 
be positioned in the 5‘ or 3‘ regions of a gene. In addition, 
the position of a silencing element for decreasing or inhib 
iting transcription is independent of both its orientation and 
distance from a transcription start site. In general, silencing 
elements of the invention reduce transcription of gene 
expression by at least 10%. Preferably, the reduction of 
transcription is at least 20%, more preferably at least 40%, 
and most preferably 90% relative to a transcriptional regu 
latory region that does not contain a silencing element. 
By “obtained from a gene” is meant that the nucleotide 
sequence of a regulatory element is based on sequence 
information included in a naturally-occurring plant gene 
(e.g., the EAS4 promoter region of Nicotiana). Once 
identi?ed, the silencing regulatory element according to the 
invention is obtained from a natural source or can be 
prepared according to any standard method (e.g., by recom 
binant methods or chemical synthesis). 
By “isoprenoid synthase gene” is meant a gene that 
encodes a polypeptide Which is capable of catalyZing a 
6,002,071 
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reaction involving the intramolecular carbon-carbon bond 
formation of an allylic diphosphate substrate (for example, 
a C10, C15, or C2O allylic diphosphate substrate) to an 
isoprenoid product (for example, a monoterpene, diterpene, 
sesquiterpene, or sterol product). Examples of such iso 
prenoid synthase genes include, Without limitation, monot 
erpene synthases (for example, limonene synthase), diter 
pene synthases (for example, casbene synthase), and 
sesquiterpene synthases (for example, 5-epi-aristolochene 
synthase, vetispiradiene synthase, and cadinene synthase) 
that are responsible for cycliZation of geranyl diphosphate 
(GPP), geranylgeranyl diphosphate (GGPP), famesyl 
diphosphate (FPP), respectively. 
By “epi-5-aristocholene synthase” or “EAS” is meant an 
enZyme capable of catalyzing the cycliZation of trans, trans 
farnesyl diphosphate to the bicyclic intermediate epi-5 
aristocholene. 
By “operably linked” is meant that an isoprenoid synthase 
gene silencing regulatory element and a plant transcriptional 
regulatory region are connected in such a Way as to reduce 
or eliminate gene expression When the appropriate mol 
ecules (e.g., transcriptional proteins) are bound to the silenc 
ing regulatory sequence(s). 
By “polypeptide” is meant any chain of amino acids, 
regardless of length or post-translational modi?cation (e.g., 
glycosylation or phosphorylation). 
By “transformed plant cell” is meant a cell into Which (or 
into an ancestor of Which) a recombinant nucleotide 
sequence (e.g., the EAS4 promoter) has been introduced by 
means of recombinant DNA techniques (e.g., those tech 
niques described herein). 
By “plant cell” is meant any self-propagating cell 
bounded by a semi-permeable membrane and containing a 
plastid. Such a cell also requires a cell Wall if further 
propagation is desired. Plant cell, as used herein includes, 
Without limitation, algae, cyanobacteria, seeds, suspension 
cultures, embryos, meristematic regions, callus tissue, 
leaves, roots, shoots, gametophytes, sporophytes, pollen, 
and microspores. 
By “transgenic” is meant any cell Which includes a DNA 
sequence Which is inserted by arti?ce into a cell and 
becomes part of the genome of the organism Which develops 
from that cell. As used herein, the transgenic organisms are 
generally transgenic plants, and the DNA is inserted by 
arti?ce into the genome of the organism. 
By “isolated DN ” is meant DNA that is free of the 
sequences Which, in the naturally-occurring genome of the 
organism from Which the DNA of the invention is derived, 
?ank it. The term therefore includes, for example, a recom 
binant DNA silencing regulatory element Which is incorpo 
rated into a vector; into an autonomously replicating plasmid 
or virus; or into the genomic DNA of a prokaryote or 
eukaryote; or Which exists as a separate molecule (e.g., 
Within a promoter region) independent of other sequences. It 
also includes a recombinant DNA regulatory element Which 
is part of a hybrid gene that encodes a polypeptide sequence. 
Other features and advantages of the invention Will be 
apparent from the folloWing description of the preferred 
embodiments thereof, and from the claims. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1A is a schematic illustration shoWing the map of the 
EAS4 promoter region. The location of polymerase chain 
reaction (PCR) primers used for cloning and producing 
various probes and competitors are shoWn as small arroWs 
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and fragments having letter designations A—E. The large 
arroW at the right of the map represents the EAS4 open 
reading frame. The bent arroW With the +1 designation 
indicates the EAS4 transcription start site (position 1299 (5‘ 
GTA +1G 3‘) as depicted in SEQ ID NO: 5); and the position 
of the TAC-box is designated by a solid vertical rectangle 
enclosed Within Fragment C. 
FIG. 1B is a panel of photographs shoWing the results of 
electrophoretic mobility shift assays (EMSA) using Frag 
ments A, E, and B in the presence of nuclear and Whole cell 
extracts that Were prepared from control and elicitor-treated 
cells. Binding assays contained one microgram dI-dC, one 
nanogram radiolabelled DNA probe, and tWo nanograms of 
protein extract. Nuclear (designated nuc) and Whole cell 
extracts (designated Wce) Were prepared from control cells 
(designated C) or cells that Were elicited With cellulase 
(designated E) for three hours. 
FIG. 1C is a photograph shoWing the results of electro 
phoretic mobility shift assays using Fragment D that Were 
incubated in the presence of nuclear (designated nuc) and 
Whole cell (designated Wce) extracts prepared from control 
or elicitor-treated cells. Assays Were performed as in FIG. 
1B, except that a 50-fold molar excess of Wild-type Frag 
ment D or Fragment D containing mutation M2 (as illus 
trated in FIG. 2B) Was included as speci?c competitors in 
these assays. 
FIG. 2A is a panel of photographs illustrating the identi 
?cation of the major protein binding site in the EAS4 
promoter. Methylation interference (MI) and DNaseI 
(DNase) footprinting analyses Were performed using Frag 
ment C labeled at the 5‘ end of the coding or non-coding 
strand. Stars indicate the positions Where methylation of 
guanine bases interferes With protein extract binding. Solid 
lines de?ne regions that Were partially protected from 
DNaseI cleavage. Lane marker designations are as folloWs: 
G refers to guanine-speci?c cleavage reaction; F refers to 
free (unbound) DNA after electrophoretic mobility shift 
assay (EMSA); C refers to DNA bound by control nuclear 
extract; and E refers to DNA bound by protein in nuclear 
extract from elicitor-treated cells. 
FIG. 2B is an illustration shoWing the nucleotide 
sequences of the WT-TAC-Box and the M2-TAC-Box. The 
underlined sequences in WT-TAC-Box shoW the reiterated 
TAC-box, and stars indicate the positions Where methylation 
of guanine interferes With protein binding. The boxed nucle 
otides in M2-TAC-Box represent nucleotides mutated using 
site-directed mutagenesis. 
FIG. 3A is a photograph of an EMSA that Was performed 
using extracts prepared from control cells (lanes 2, 6, and 7) 
or cells treated With elicitor for one-half hour (lanes 3, 8, and 
9), three hours (lanes 4, 10, and 11), or tWelve hours (lanes 
5, 12, and 13). Proteins Were diluted to one microgram per 
microliter With alkaline phosphatase assay buffer and then 
immediately added to binding reaction mixtures (lanes 2—6); 
or Were added after forty-?ve minutes of incubation at 37° 
C. Without (lanes 6, 8, 10, and 12) or With (lanes 7, 9, 11, and 
13) alkaline phosphatase. Binding reactions for EMSA con 
tained 0.5 pmole TAC-box double stranded oligonucleotide 
probe, tWo picograms of poly dI-dC, and tWo micrograms 
protein extract in a total volume of ten microliters. Only the 
portion of the gels containing the protein-DNA complexes 
are shoWn in FIGS. 3A—3C. 
FIG. 3B is a panel of photographs shoWing an EMSA 
using protein extracts prepared from control Whole cell 
extracts that Were diluted to one microgram per microliter in 
binding buffer that Was supplemented With MgCl2 or EDTA 
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and Was added to binding assays immediately (lanes 1—4); or 
Was added to the binding assays after incubation at 37° C. 
for forty-?ve minutes (lanes 5—8). 
FIG. 3C is a photograph showing an EMSA using Whole 
cell extracts prepared from three hour elicitor-treated cells 
With (lane 8) or Without added MgCl2 (lanes 1—7, 9—11) or 
EDTA (lanes 10, 11) and incubated at 37° C. for varying 
durations prior to addition to binding reactions. The extract 
used for lane 9 Was ?rst incubated for thirty minutes Without 
MgCl2. 
FIG. 4A is a photograph illustrating the EMSA of various 
fractions obtained from DNA af?nity chromatography frac 
tions. Ten microliters of binding assays containing one 
nanogram of Fragment C probe (FIG. 1A) and tWo micro 
grams of protein sample Were loaded in each lane. The lane 
designated “E-3 hr” refers to the protein sample prepared 
from cells treated With elicitor for three hours that Was 
loaded onto the column; batch 1 and batch 2 refer to tWo 
identical samples processed sequentially; and batch 3 refers 
to the combination of How through (FT1 and FT2) and loW 
salt (0.1 M KCl ) Washes that Were combined and passed 
over the column a second time to extract additional binding 
activity. In the ?nal three lanes, protein samples Were diluted 
10-fold (0.1X) or had 0.5 micrograms dI-dC added to the 
binding assay. Stars indicate fractions pooled and dialyZed to 
yield the preparation designated E-DAC, that Was then 
ultra?ltered to yield the preparation designated E-DAC-UF. 
FIG. 4B is a photograph illustrating EMSA analysis of 
various fractions obtained during Mono-S fast protein liquid 
chromatography (FPLC). Binding assays Were performed as 
above, except that tWo microliters of a 10-fold dilution of 
each fraction Was used. E-DAC-UF refers to the sample 
loaded onto the gel, and numbers correspond to speci?c one 
milliliter fractions obtained from the column. Stars indicate 
fractions pooled and dialyZed to yield the preparation des 
ignated E-FPLC, Which Was then ultra?ltered to yield the 
preparation E-FPLC-UF. 
FIG. 5 is a photograph of an SDS-PAGE analysis of 
various TBBF preparations. Lane 1, control-Whole cell 
extract; lane 2, C-DAC-UF; lane 3, C-FPLC-UF; lane 4, 
C-nuclease; lane 5, E-Whole cell extract; lane 6, E-DAC-US; 
lane 7, E-FPLC-UF; and lane 8, E-nuc. 
FIG. 6A is a photograph of a DNase I footprinting 
analysis using puri?ed TBBF preparations. 
FIG. 6B is a graph shoWing the amount of TBBF bound 
to TAC-box probe in the presence of various non-speci?c 
DNAs. 
FIG. 7A is a schematic illustration shoWing the location of 
the Wild-type TAC-box element (WT-TAC-Box) and the 
mutated TAC-box element (M2-TAC-Box) in the EAS4 
promoter:GUS gene fusions. 
FIG. 7B is a graph shoWing the comparison of GUS 
activity in transgenic plants containing the Wild-type TAC 
box element (WT-TAC-Box) and the mutated TAC-box 
element (M2-TAC-Box) that Were treated With elicitin. 
Tobacco plants Were transformed With the GUS gene under 
the control of EAS4-266 to+73 region containing either the 
Wild type or mutated TAC box. Leaves of F1 progeny Were 
in?ltrated With Water or the elicitor cryptogein (1 pig/ml), 
protein Was extracted from the in?ltrated areas, and assayed 
for GUS activity. Each pair of bars (control and elicitor) 
represents an independent transgenic line. The height of 
each bar represents the mean value from at least 3 plants. 
DETAILED DESCRIPTION OF THE 
INVENTION 
There noW folloWs a description of an analysis of DNA 
binding activities that recogniZe speci?c sequences on the 
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promoter region of the 5-epi-aristolochene synthase gene 
designated EAS4. The binding site of one activity Was 
identi?ed by footprinting methods, and then mutated to 
determine the effect on protein binding and promoter activ 
ity. The DNA binding activity Was characteriZed 
biochemically, and the protein responsible for this activity 
Was puri?ed. In addition, functional identi?cation of this 
cis-element in the EAS4 promoter Was veri?ed by trans 
forming into tobacco a series of promoter constructs con 
taining the silencing element fused to the GUS reporter 
gene. 
These examples are provided for the purpose of illustrat 
ing the invention, and should not be construed as limiting. 
Identi?cation of EAS Promoter Region Binding Activity 
To understand the mechanism by Which the EAS4 gene is 
regulated, the EAS promoter region (SEQ ID NO: 5) Was 
divided into ?ve overlapping nucleotide fragments, desig 
nated Fragments A—E (FIG. 1A), and each fragment Was 
examined for its ability to bind proteins that Were prepared 
from nuclear or Whole cell extracts of tobacco cell suspen 
sion cultures. These experiments shoWed that no speci?c 
DNA-binding activities to Fragments A or E Were detected 
in nuclear extracts When examined using electrophoretic 
mobility shift assays (EMSA) (data not shoWn). Because 
proteins can be lost While preparing isolated nuclei, Whole 
cell extracts Were also examined for their ability to bind 
Fragments A—E. 
The results of these experiments indicated that several 
Weak binding activities to Fragments A—E Were present in 
Whole cell extracts (FIG. 1B, lanes 1—6), and a major 
DNA-binding activity Was observed in nuclear and Whole 
cell extracts Was observed that bound Fragments B (FIG. 
1B, lanes 7—11) and D (FIG. 1C, lanes 1—5). Restriction 
enZyme analysis indicated that the major DNA-binding 
activity recogniZed a sequence in a region Where these tWo 
fragments overlapped (data not shoWn). As shoWn in FIG. 
1C, three migrating complexes (designated F, I, and S 
referring to fast, intermediate, and sloW-migrating 
complexes, respectively) Were observed in binding reactions 
prepared using Fragment D and different extracts. Nuclear 
extracts from both control (C-nuc) and elicitor-treated 
(E-nuc) cells formed the fast migrating complex, and this 
DNA-binding activity Was less abundant in nuclear extracts 
that Were prepared from elicitor-treated cells. 
Control Whole cell extract formed all three complexes, 
With complex I (intermediate) being the most abundant. 
Whole cell extracts prepared after elicitor-treatment for 
three hours predominantly formed complex S (sloW). The 
addition of a ?fty-fold excess of unlabelled Fragment D 
(FIG. 1C, lanes 6—9) reduced the amount of labelled Frag 
ment D that Was bound, thereby demonstrating sequence 
speci?city. 
Identi?cation of a Protein Binding Site 
To identify the speci?c nucleotide bases comprising the 
binding site for the activity identi?ed above, methylation 
interference (MI) and DNase I footprinting experiments 
Were performed (FIG. 2A). Fragment C of the EAS pro 
moter region Was partially methylated on guanines, mixed 
With nuclear protein from control or elicitor-treated cells, 
and analyZed using EMSA to separate the bound from 
unbound DNA. After gel puri?cation, the DNA Was cleaved 
at the methylated sites and the resulting fragments Were 
resolved on a denaturing 6% polyacrylamide sequencing gel 
(FIG. 2A). DNA fragments methylated on the non-coding 
strand guanines at positions —239 and —234 (FIG. 
2A—designated by stars) Were underrepresented in the 
bound DNA fractions (FIG. 2A, lanes C and E), indicating 
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that methylation at these positions interfered With protein 
binding. Methylation of the guanine at position —237 of the 
coding strand had no effect on DNA binding. 
DNase I footprinting analysis also implicated this same 
region Within Fragment C as the protein binding site. In the 
presence of nuclear extract prepared from either control or 
elicitor-treated cells, the region from —237 to —242 of the 
coding strand and from —236 to —242 on the non-coding 
strand Was partially protected from DNaseI digestion (FIG. 
2A, solid lines). These observations provided additional 
evidence that the DNA-protein complexes that formed in the 
presence of Fragments B and D Were due to binding Where 
these tWo fragments overlapped (i.e., Within Fragment C). 
Together the results from methylation interference and 
DNaseI footprinting indicated that this nucleotide sequence 
Was indeed recogniZed by the DNA-binding activity found 
in nuclear extract prepared from control and elicitor-treated 
cells. This sequence, 5‘ CTACAGTAC 3‘ (SEQ ID NO: 6) as 
been designated the TAC-box, due to the presence of reit 
erated “TAC” motifs. 
To con?rm that the TAC-box Was responsible for the 
binding activities observed by EMSA, tWo nucleotides 
Within the TAC-box Were altered via oligonucleotide medi 
ated site-directed mutagenesis (FIG. 2B, M2-TAC-Box). A 
DNA fragment containing the mutated TAC-box Was mini 
mally bound by nuclear and Whole cell extracts from control 
and elicitor-treated cells (data not shoWn) and did not 
compete the binding of Wild type Fragment D probe (FIG. 
1C, lanes 10—13). This result provided further evidence 
indicating that the TAC-box element is required for protein 
binding. 
Characterization of TAC-Box Binding Activity 
The differences in the migration of TAC-box-protein 
complexes betWeen Whole cell extracts from control and 
elicitor-treated cells suggested that the TAC-box binding 
factor might undergo modi?cation during the course of the 
cellular response resulting from elicitor treatment. To exam 
ine this possibility, Whole cell extracts Were prepared from 
cells treated With elicitor for varying amounts of time (FIG. 
3A, lanes 1—5). Previous studies indicated that EAS mRNA 
accumulation is most rapid from tWo to six hours folloWing 
elicitor-treatment. After this time mRNA levels began to 
decrease and returned to control levels by tWenty-four hours. 
While Whole cell extracts prepared from control cells gen 
erated predominantly complex I; Whole cell extracts pre 
pared from cells treated With elicitor for thirty minutes 
generated the formation of complex S, although complex I 
Was also identi?ed in Whole cell extracts prepared from cells 
at the peak of EAS transcription (i.e., three hours after 
elicitor treatment) formed complex S; and Whole cell 
extracts prepared from cells tWelve hours after elicitor 
treatment formed complex I. These results indicated that 
alterations in the TAC-box-protein complex are correlated 
With the induction pattern of EAS gene transcription. 
To examine the nature of the differences in complex 
migration, the effect of dephosphorylation on binding activ 
ity (FIG. 3A, lanes 6—13) Was examined. Whole cell extracts 
Were diluted approximately ten-fold in alkaline phosphatase 
buffer (20 mM Tris-HCl, pH 8.5), and the extracts Were 
incubated at 37° C. for forty-?ve minutes prior to EMSA 
analysis. Surprisingly, the protein-DNA complexes Were 
found to shift from sloWer to faster migrating forms When 
the extracts Were incubated at 37° C. in the absence of 
alkaline phosphatase (compare lanes 2 and 6; 3 and 8; 4 and 
10; and 5 and 12 of FIG. 3A). Incubation With alkaline 
phosphatase therefore decreased the total amount of binding 
activity, and also partially inhibited the shift in complex 
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migration. In separate experiments, a thirty minute incuba 
tion at 37° C. With or Without alkaline phosphatase had no 
effect on the binding activity of the nuclear extracts (data not 
shoWn). 
To determine the lack of shift in complex migration under 
these conditions, Whole cell extracts prepared from control 
cells Were diluted and supplemented With MgCl2 or EDTA, 
and this mixture Was then immediately added to binding 
assays or, alternatively, incubated for forty-?ve minutes at 
37° C. prior to addition of MgClzzEDTA (FIG. 3B). EMSA 
revealed that the presence of MgCl2 or EDTA did not affect 
the migration of the TAC-box-protein complexes (FIG. 3B, 
lanes 1—4). After forty-?ve minutes the sample containing 
only 4 mM Mg2+ produced mostly complex F; incubation 
With 9 mM Mg2+ produced complexes F and I in equal 
abundance; and 24 mM Mg2+ had no effect on complex 
mobility. In addition, EMSA of samples incubated With 
EDTA (FIG. 3B, lane 8) indicated that binding activity Was 
inhibited, indicating that divalent cations are required for 
TAC-box protein binding. Our results also indicated that cell 
extracts prepared With buffers lacking Mg2+ contained no 
TAC-box binding activity (data not shoWn). 
The shifts in complex mobility after incubation of Whole 
cell extracts prepared from elicitor-treated cells at 37° C. in 
the presence of loW Mg2+ concentrations Were also moni 
tored during a sixty minute incubation (FIG. 3C, lanes 1—7). 
During this period, a decrease in complex S Was observed to 
coincide With an increase in complex I. In addition, a 
decrease in the total amount of TAC-box binding activity 
Was observed. No changes in complex migration Were 
observed When this extract Was incubated With high Mg2+ 
concentrations. Addition of Mg2+ after thirty minutes of a 
total sixty minutes incubation period prevented alteration of 
the binding activity beyond that Which occurred during the 
?rst thirty minutes. Again, incubation under these conditions 
in the presence of EDTA Was found to inhibit TAC-box 
binding activity. 
Puri?cation of TAC-box Binding Factor 
Several attempts to identify the TAC-box binding factor 
(TBBF) by southWestern blot as described by Miskimins et 
al. (Proc. Natl. Acad. Sci. 82:6741—6744, 1985) With crude 
protein extracts Were unsuccessful. To further characteriZe 
this binding activity, We puri?ed TBBF using DNA-af?nity 
chromatography. Crude Whole cell extract prepared from 
three hour elicitor-treated cells Was mixed With ?sh sperm 
DNA in ZNG buffer to bind non-speci?c DNA-binding 
proteins. This mixture Was divided into tWo batches and 
passed separately over a 5 mL bed volume TAC-box 
sepharose column. The column Was then Washed With ZNG 
buffer containing 0.1 M KCl to elute Weakly bound proteins, 
and With ZNG buffer containing 0.5 M KCl to elute TBBF 
from the immobiliZed DNA af?nity column. The ?rst tWo 
?oW through (referred to as FT1 and FT2) and loW salt 
Washes Were combined and passed over the column a second 
time to extract the remaining binding activity (FIG. 4A). 
EMSA using (FT 1) exhibited less TAC-box binding activity 
than the crude sample that Was applied to the column (E-3 
hours), indicating that a large percentage of the DNA 
binding activity Was retained on the column. Minimal TBBF 
eluted from the column during loW salt Washes; hoWever, 
protein binding activity Was eluted in the presence of 0.5 M 
KCl (FIG. 5, fractions 1—3, 7—8, 12). Note that these binding 
assays did not contain non-speci?c DNA, except that Which 
Was added to the extract before chromatography. Thus, ?sh 
sperm DNA Was present in the original sample, the How 
through eluants (FT1 and FT2), and the loW salt Washes, but 
not in the high salt fractions. 
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Preliminary experiments indicated that the affinity 
puri?ed TBBF Was capable of binding DNA non 
speci?cally, even after the high af?nity binding sites had 
been occupied. Therefore, When TBBF Was present in excess 
over the amount of probe, multiple proteins Were observed 
to bind to a single DNA fragment. This resulted in the 
formation of a ladder, With each rung containing one more 
protein bound than the loWer rung. In addition, this effect 
Was visualiZed by comparing different amounts of a high 
activity protein fraction or by adding non-speci?c DNA. 
Thus, the presence of a 500-fold excess of non-speci?c DNA 
(fraction 2+dI-dC) Was found to decrease the number of 
higher-order complexes such that the majority of the probe 
Was bound by only one or tWo TAC-box binding factors. 
Decreasing the amount of TBBF added to the binding assays 
by 90% (0.1><fraction 2) had the same effect as adding 
non-speci?c DNA. Finally, When a double-stranded oligo 
nucleotide Was used as the probe, one complex Was found to 
form, even When the amount of binding activity Was present 
in excess (data not shoWn). 
High salt fractions containing the binding activity (~30 
mL) Were combined and dialyZed against ZNG buffer lack 
ing KCl, and ultra?ltered to approximately 5 mL. Analysis 
of these processed DNA-affinity chromatography fractions 
and a similar preparation from control cells by SDS-PAGE 
and silver staining revealed ?ve to seven major polypeptide 
bands (FIG. 5, lanes 2 and 6). Since southWestern blot 
analysis again failed to identify a speci?c band as the 
TAC-box binding protein, the partially puri?ed protein 
preparation Was further fractionated by fast-protein liquid 
chromatography (FPLC). 
To determine the appropriate ion exchange column for 
this puri?cation step, aliquots of the partially puri?ed TBBF 
Were mixed With the anion exchange resin Q-sepharose or 
the cation exchange resin S-sepharose. After centrifugation 
and removal of the supernatant containing unbound protein, 
the sepharose Was Washed consecutively With ZNG buffer 
and With ZNG buffer containing 1.0 M KCl. Analysis of the 
binding activity in each fraction by EMSA revealed that 
TBBF bound S-sepharose but not Q-sepharose (data not 
shoWn). 
The DNA-af?nity chromatography puri?ed TBBF prepa 
rations Were then loaded onto a Mono-S column, and the 
bound proteins Were eluted using a linear gradient of KCl in 
Z buffer. As shoWn in FIG. 4B, fractions one through eight 
Which corresponded to the initial ?oW through of the 
column, contained only a small amount of TAC-box binding 
activity as compared to the (E-DAC-UF) sample that Was 
loaded onto the column. Although little binding activity Was 
eluted in the presence of loW KCl concentrations, protein 
binding activity Was eluted rapidly When the level of KCl 
reached approximately 150 mM (FIG. 4B, fractions 22 
through 24). These fractions Were pooled, desalted, and 
concentrated by ultra?ltration. The fractions Were then sta 
biliZed With glycerol and stored at —80° C. 
Puri?cation of TBBF Was qualitatively assessed using 
SDS-PAGE, and the separated proteins Were then visualiZed 
using silver-staining (FIG. 5A). The FPLC-puri?ed sample 
from control cells shoWed tWo major bands at 17 and 19 kD 
in approximately equal abundance. Minor polypeptide bands 
Were detected at 16 and 20 kD (FIG. 5A, lane 3). A similar 
preparation from elicitor-treated cells contained contaminat 
ing protein but the 17 and 19 kD polypeptides Were visible, 
indicating that these polypeptides Were the principal com 
ponents of TBBF. Polypeptides of 23, 31, and 37 kD Were 
found to co-purify With TBBF during DNA-af?nity chro 
matography using extracts that Were prepared from both the 
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control and elicitor-treated cells (FIG. 5, compare lanes 2 
and 6). The decreased abundance of the 37 kD band in the 
preparation from control cells relative to that from elicitor 
treated cells Was not likely to be signi?cant since a different 
preparation from control cells shoWed the presence of this 
band in higher amounts. Nuclear extracts from control and 
elicitor-treated cells also contained a strong band that comi 
grated With the 17 kD band of puri?ed TBBF, Whereas the 
nuclear extract band that co-migrated With the 19 kD 
polypeptide Was relatively Weak. 
To quantify the amount of DNA binding activity recov 
ered after each puri?cation step, EMSA Was performed in 
the presence of an excess concentration of double-stranded 
oligonucleotide containing the TAC-box DNA element. 
While the larger Fragment C probe that Was used to monitor 
binding activity during puri?cation Was valuable for the 
visual identi?cation of fractions With high levels of binding 
activity, utiliZation of a probe that bound one factor Was 
required for quantitation. Non-speci?c competitor DNA Was 
not present in these quantitative assays. As a result, non 
speci?c DNA-binding proteins that formed similarly 
migrating complexes likely caused a slight overestimate in 
the activity measurement With crude extracts, but not With 
the puri?ed preparations. With this in mind, TBBF Was 
puri?ed at least 750-fold and 461-fold from control and 
three hour elicitor-treated cells, respectively (Table I). 
TABLE I 
Puri?cation of TBBF from control and elicitor-treated cell cultures. 
activity 
volume protein (unitsa x recovery sp.activity fold 
Sample (mL) (pg) 10’3) (%) (units/Mg) purif. 
C-WCE 11 180,000 3487 100 19.4 — 
C-DAC 70 280 990 28.4 3536 182 
C-DAC-UF 8 256 1043 29.9 4073 210 
C-FPLC 4 25 237 6.8 9487 489 
C FPLC-UF 0.5 17.9 260 7.5 14551 750 
E-WCE 3 50,000 811 100 16.2 — 
E-DAC 27 216 284 35.1 1316 81 
E-DAC-UF 5 185 267 33 1444 89 
E-FPLC 3 30 175 21.5 5817 359 
E-FPLC-UF 0.275 11 82 10.1 7469 461 
3One unit of binding activity is de?ned as the amount of activity necessary to 
bind 1 frnole of double stranded TAC-box oligonucleotide probe. 
CharacteriZation of the Puri?ed Protein 
The FPLC-puri?ed TBBF preparation from three hour 
elicitor-treated cells Was also used in a quantitative footprint 
analysis to examine the relative speci?city of the binding 
activity, or preference for the TAC-box over non-speci?c 
DNA. In each experiment, Fragment C (8.8 fmole) Was 
labelled on the coding strand and the labelled fragment Was 
incubated With increasing amounts of TBBF, While the 
amount of poly dI-dC or ?sh sperm DNA Was varied 
betWeen experiments. After DNaseI treatment and 
precipitation, the DNA Was separated on a sequencing gel 
and analyZed. 
A representative series of experiments With increasing 
amounts of TBBF is shoWn in FIG. 6A, With the primary 
footprint indicated by the solid bracket. We observed that the 
footprint With the protein puri?ed from Whole cell extracts 
Was larger than the footprint With the crude nuclear extract 
(FIG. 2A). This footprint clearly extended from the strong 
band at —232 doWn to the band corresponding to —245, 
neither of Which Was protected by the crude nuclear extracts. 
This extended footprint included the tWo ACTC motifs 
spaced exactly 10 bp apart, and therefore on the same face 
of the helix. We also observed that there Was a slight change 
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in the DNase I sensitivity pattern at approximately —275 in 
the presence of very large amounts of TBBF (dashed 
bracket). This area has the nucleotide sequence TAaAG 
TAaT (loWer case letters refer to non-matching nucleotides), 
Which matches the core TAC-box sequence at seven of nine 5 
positions. 
Quantitative analysis revealed that, as the protein concen 
tration increased, the percentage of bound probe increased to 
100% (FIG. 6B). Fish sperm DNA (fs DNA) inhibited 
binding of the probe and Was found to increase the disso 
ciation constant (Kd) to a greater extent than dI-dC, pre 
sumably due to the random occurrence of the TAC-box 
10 
-7 4 0 c gggctgcAGGCGTAAAGATACATTATACC (SEQ ID NO: 
-5 7 1c gggctgcAGGTGAATGTCAGGGCTTATGC (SEQ ID NO: 
—5 2 6 n CTGGCAGGGCATAAGTATCG (SEQ ID NO: 
—3 4 9 c GggcTgCAGTTCATCAAAGTGGACTCTGC (SEQ ID NO: 
—266c GggcTgcagATTTGATAGTTCCAGGAAAC (SEQ ID NO: 
—2 33m AGTACTGTAGAnTTGTTTCC (SEQ ID NO: 
—1 60¢ GgnnnnnnGATCAATAGACC (SEQ ID NO: 
—1 47m gGGCtgCaGGGGTCTATTGATCCAGTTTCC (SEQ ID NO: 
+7 6n GgGGatccTGCTAATTAAAGATGAGTG (SEQ ID NO: 
TAC-M2n CAAAATAAGGGAGTACaCTAGAGTTGTTTCC (SEQ ID NO: 
dsTACc agctACTCTACAGTACTC (SEQ ID NO: 
dsTACn agctGAGTACTGTAGAGT (SEQ ID NO: 
element in ?sh sperm DNA. Under all conditions examined, 25 
the Kd ranged from 1.5><10_1°M to 1.5><10_9M. 
TAC-Box Element Functions as a Silencer 
Transgenic tobacco plants containing promoter fusions to 
the [3-glucuronidase (GUS) coding region Were constructed 
to assess the function of the TAC box (FIG. 7A). The 
chimeric gene fusions consisted of the EAS4 5‘-untranslated 
region and 266 nucleotides upstream of the EAS transcrip 
tion start site and included either the Wild type or mutated 
TAC box. F1 plants Were groWn to the ten to tWelve leaf 
stage and tWo young, fully expanded leaves Were in?ltrated 
on opposite sides of the midvein With Water (control) and a 
1 ng/mL solution of cryptogein, an elicitor of defense 
responses in tobacco. TWelve hours later, 2.5 cm diameter 
leaf discs Were cut from the in?ltrated areas, homogeniZed 
With a mortar and pestle in GUS assay buffer, and protein 
extracts Were assayed for GUS activity. 
As shoWn in Table II and FIG. 7B, the leaves of plant lines 
transformed With the Wild-type promoter contained a mini 
mal amount of GUS activity When in?ltrated With Water, and 
approximately eleven-fold higher levels after elicitor treat 
ment. Plant lines containing the mutated promoter upstream 
of the GUS gene shoWed a similar expression pattern, except 
that the absolute activity levels Were tWo to three-fold higher 
than in transgenic plants containing the Wild-type promoter. 
This increase in GUS activity Was noted both in response to 
the control and elicitor treatments. These results indicated 
that, in the context of the truncated promoter, that the 
TAC-box element functions to suppress gene expression. 
30 
40 
45 
TABLE II 
GUS activity nmoles/hr/mg 55 
median mean : s.d. 
—266 (WT-TAC) control 13 23 r 26 
elicitor 144 140 r 83 
—266 (m2-tac) control 37 64 r 76 60 
elicitor 376 299 r 156 
The experiments described above Were carried out using 
the folloWing techniques. 
Oligonucleotides and Probes 
Oligonucleotides Were synthesiZed according to standard 
methods and are designated by position (number) and cod 
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ing strand (c) or noncoding strand (n) Within the EAS4 
promoter (see beloW and FIG. 1A). Bases shoWn in loWer 
case correspond to nonhomologous bases added to incorpo 
rate a restriction site or mutation (n is A, T, G, or C). 
1) 
8) 
9) 
1o) 
11) 
12) 
13) 
14) 
15) 
16) 
17) 
1s) 
Oligonucleotide primers Were end-labelled With y-32P 
ATP and radiolabelled DNA fragments Were synthesiZed by 
standard polymerase chain reaction (PCR) protocols using 
the end-labelled primers as folloWs. Primer labeling reac 
tions contained 25 pmole oligonucleotide, 1 nL 10><T4 
kinase buffer (0.5 M Tris-HCl pH 7.6, 0.1 M MgCl2, 50 mM 
DTT, 1 mM spermidine HCl, 1 mM EDTA), 25 nCi y-32P 
ATP (3000 Ci/mmole), and 10 units of T4 kinase in a total 
volume of ten microliters. After incubation for thirty min 
utes at 37° C., the folloWing components Were added for the 
PCR reaction: 5 nL dNTPs (2.5 mM), 5 ML 10><kinase-PCR 
transition buffer (20 mM Tris pH 9.5, 0.5 M KCl, 0.1% 
TWeen-20, 0.1% gelatin, 0.1% Nonidet P-40), one to ten 
nanograms template DNA (EAS4 promoter cloned in 
pBluescript), one unit Taq Polymerase (Gibco-BRL), ?fty 
pmole second oligonucleotide (unlabelled), and Water to a 
?nal volume of ?fty microliters. Thermal cycling Was per 
formed With an annealing temperature of 50° C. for thirty 
tWo cycles. PCR products Were resolved on non-denaturing 
12% (80:1) polyacrylamide gels, Which Were then exposed 
to Kodak X-OmatAR ?lm for thirty seconds to tWo minutes 
to visualiZe the position of the probe in the gel. The 
radiolabelled fragment Was excised from the gel, embedded 
in one percent agarose, and the radiolabelled fragment Was 
then electrophoresed onto DE-81 paper (Whatman) or 
NA-45 membrane ?lters (Schleicher and Schuell). Next, the 
radiolabelled probe Was eluted from the paper or membrane 
in elution solution (20 mM Tris pH 8.0, 2 mM EDTA, 1.5 M 
NaCl) for tWo hours at 60° C. and precipitated With tWo 
volumes ninety-?ve percent ethanol. 
Extract Preparations 
Tobacco cell suspension cultures Were treated With elici 
tor (0.1 ng/mL cellulase) as described by Vogeli and Chap 
pell (Plant Physiol. 94:1860—1866, 1990) and nuclei from 
these cultures Were isolated as described by Watson and 
Thompson (Meth. Enzymol. 118:57—75, 1986) and extracted 
according to Dignam et al. (NuclAcids Res. 11:1475, 1983). 
Extracts from Which TBBF Was puri?ed Were prepared 
using a bead beater as described by Arias et al. (Plant Cell 
5:485—496, 1994). Protein Was determined by the Bradford 
method using Bio-Rad protein assay dye (Bio-Rad). 
Whole cell extracts Were prepared by a modi?cation of 
the procedure described by Arias et al. (Plant Cell 
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5 :485—496, 1994) as follows. Approximately 300 milliliters 
of tWo-day-old tobacco cell suspension culture Were ?ltered 
on a Wide pore (~05 mm) nylon mesh, the cells Were 
Washed With 200 milliliters of ice-cold Water, Weighed 
(approximately seventy-?ve to one hundred grams), and 
transferred to a chilled mortar. Approximately three grams of 
polyvinylpolypyrrolidone (PVPP) Were sprinkled onto the 
cells, and the cells Were then ground With a pestle. A small 
amount (~10 mL) of cold homogenization buffer Was added 
to the cells and grinding Was resumed. HomogeniZation 
buffer contained 0.2 M Tris, 0.39 M (NH4)2SO4, 10 mM 
MgSO4, 20% glycerol, 2 mM EDTA, 5 mM EGTA, and 
2.5% dextran sulfate and Was adjusted to pH 7.9 With glacial 
acetic acid. Immediately before use, 5 mM DTT, 1 mM 
PMSF, 2.5 ag/mL antipain, 0.35 ag/mL bestatin, and 0.4 
ag/mL pepstatinAWere added to the buffer. The ground cells 
Were transferred to a large centrifuge bottle, along With 190 
milliliters of cold homogeniZation buffer that Was used to 
rinse the mortar and pestle, and ?fteen drops of octanol Were 
added to prevent foaming during homogeniZation. Homog 
eniZation Was performed using a polytron at setting eight, 
three times for one minute, With chilling on ice betWeen 
homogeniZations. The homogenate Was then ?ltered through 
Wide pore nylon mesh as described above, and the ?ltrate 
Was centrifuged at 10K (Sorvall SS34) for seven minutes. 
The supernatant Was brought to 0.9 M (NH4)2SO4 by the 
dropWise addition of 4 M (NH4)2SO4 (pH 7.0) over thirty to 
sixty minutes. After stirring for thirty minutes, the extract 
Was centrifuged at 15K in (Sorvall SS34) for thirty minutes, 
and the supernatant Was decanted into a chilled beaker. Solid 
(NH4)2SO4 (0.35 p/mL homogenate) and 1 M KOH (10 
aL/g (NH4)2SO4) Were sloWly added over one hour While 
stirring, the homogenate Was stirred for an additional thirty 
minutes, and then centrifuged at 15K (Sorvall SS34) for 
forty-?ve minutes. The protein pellet Was resuspended (at a 
ratio of forty-?ve microliters to one gram of cells)in Whole 
cell extract dialysis buffer (50 mM HEPES-KOH pH 7.9, 10 
mM EGTA, 10 mM MgSO4, 20% glycerol, 5 mM DTT, 0.5 
mM PMSF) containing 4 al/mL pepstatin A, 5 p/mL 
leupeptin, 25 p/mL antipain, and 35 p/mL bestatin, and then 
dialyZed overnight against tWo changes of dialysis buffer. 
Electrophoretic Mobility Shift Assays (EMSA) 
Electrophoretic mobility shift assays (EMSA) contained 
10 mM Tris (pH 7.9), 80 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 5% glycerol, and ?ve to tWenty-?ve fmole of probe 
(10,000—50,000 dpm) in a total volume of ten microliters. 
The amount of protein and non-speci?c competitor DNA is 
indicated in the legend to appropriate ?gures. Samples Were 
incubated for ?ve to ten minutes at room temperature prior 
to loading on 12% acrylamide:bis (80:1) non-denaturing 
gels. The gels Were run in 05><TBE buffer at 4° C. 
Footprinting 
Methylation interference experiments Were performed 
using nuclear extracts as described by BaldWin (In: Ausubel 
et al, Current Protocols In Molecular Biology, John Wiley & 
Sons, NeW York, 1994). 
DNase I footprinting using crude nuclear extracts used an 
approach similar to that for methylation interference. MgCl2 
(to 5 mM) and tWo micrograms DNaseI Were added to ?fty 
microliters of binding assay buffer, the reaction Was incu 
bated at room temperature for tWo minutes, and stopped by 
the addition of tWo microliters of 0.5 M EDTA. Bound and 
free DNA Were separated by EMSA, isolated as above, and 
run on a 6% polyacrylamide sequencing gel. Quantitative 
footprinting analysis using puri?ed TBBF Was accom 
plished using the procedure of BrenoWitZ et al. (In: Short 
Protocols in Molecular Biology, Ausubel et al., eds., John 
Wiley & Sons, NeW York, 1992). 
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Site-directed Mutagenesis 
Site-directed mutagenesis Was performed according to the 
method of Kunkel et al. (Meth. Enzymol. 154:367, 1987). 
The mutageniZed oligonucleotide Was designed such that 
successfully mutated plasmids Would lose the ScaI restric 
tion enZyme recognition site (5‘ AGTACT 3‘) Within the 
TAC box. 
Puri?cation of TAC-Box Binding Factor 
DNA af?nity chromatography: TAC box DNA-Sepharose 
Was prepared essentially as described by Kadonaga and 
Tjian (Proc. Natl. Acad. Sci. 83:5889—5893, 1986). Oligo 
nucleotides (dsTAC and dsTACn) Were gel puri?ed, 
annealed, ligated into multimers, and coupled to ?ve milli 
liters (bed volume) of cyanogen bromide-activated 
sepharose (Sigma). The resulting affinity matrix contained 
approximately 400,;tg DNA/5 mL sepharose. 
Crude Whole cell extracts containing 50—200 milligrams 
of protein Were diluted With cold ZNG buffer and incubated 
for thirty minutes on ice With 0.3—05 milligrams of “?sh 
sperm” DNA (Amersham) per milligram of protein. Buffer 
ZNG (25 mM HEPES-KOH pH 7.8, 12.5 mM MgCl2, 1 mM 
DTT, 0.1% Nonidet P-40) is identical to Z buffer described 
by Kadonaga and Tjian (Proc. Natl. Acad. Sci 
83:5889—5893, 1986), except that glycerol Was omitted to 
accelerate the chromatography and ultra?ltration steps. The 
protein-?sh sperm DNA mixture Was passed over the TAC 
box sepharose column and the How throughs (designated 
FT1 and FT2) Were collected as a single fraction. The 
column Was then Washed With tWenty-?ve milliliters of ZNG 
buffer supplemented With 0.1 M KCl (loW salt Wash) fol 
loWed by a 25 ML high salt Wash With ZNG buffer contain 
ing 0.5 M KCl. All fractions Were collected and assayed for 
DNA binding activity. This procedure Was repeated until the 
majority of the binding activity Was removed from the crude 
Whole cell extract. Fractions demonstrating DNA binding 
activity in EMSA Were combined, dialyZed against ZNG 
buffer, and concentrated by ultra?ltration. 
Fast Protein Liquid Chromatography (FPLC): Combined 
fractions having DNA-binding activity that Was obtained 
from DNA-af?nity chromatography (above) Were loaded 
onto a Mono-S column (Pharmacia) and eluted With a 
gradient of increasing ionic strength. Buffer AWas identical 
to ZNG buffer; B buffer also contained 0.75 M KCl. Proteins 
Were eluted at a How rate of 0.5 mL/min using the folloWing 
gradient: four minutes 0% B; forty minutes 0—33% B; 
tWenty minutes 33—100% B; four minutes 100% B. One 
milliliter fractions Were collected, and aliquots Were diluted 
ten-fold prior to EMSA analysis. Fractions that demon 
strated DNA activity in EMSA Were combined, dialyZed 
against ZNG buffer, and concentrated by ultra?ltration. 
Proteins from these fractions Were resolved by SDS-PAGE 
(Laemmli, Nature 227:680—685, 1970) using Duracryl high 
tensile strength acrylamide (Millipore) and stained With 
Silver Stain Plus (Bio-Rad). 
Transgenic Plants and [3-Glucuronidase (GUS) Assays 
Transgenic tobacco plants containing chimeric gene 
fusions consisting of the EAS4 5‘-untranslated region and 
266 nucleotides upstream of the EAS4 transcription start 
site, that included either the Wild-type (5‘ CAACTCTA 
CAGTACTCCC 3‘; SEQ ID NO: 19) or mutated TAC-box 
(5‘ CAACTCTAGTGTACTCCC 3‘; SEQ ID NO: 20), Were 
generated according to standard methods, e.g., those meth 
ods described in Chappell et al. (Transcriptional Control 
Sequences and Uses Thereof, U.S. Ser. Nos. 08/443,639, 
08/471,983, and 08/577,483, ?led May 18, 1995, Jun. 6, 
1995, and Dec. 22, 1995, respectively) and Chappell et al. 
(WO97/012076). 






